Carna Biosciences has a total of 313 patents globally, out of which 126 have been granted. Of these 313 patents, more than 59% patents are active. United States of America is where Carna Biosciences has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, Japan seems to be the main focused R&D centre and also is the origin country of Carna Biosciences.
Carna Biosciences founded in 2003, Carna Biosciences is a biotechnology company specializing in kinase-focused drug discovery for cancer, inflammatory, and neurological diseases. The company develops and manufactures kinase proteins while providing biochemical and cell-based assay services for pharmaceutical research. Its expertise in kinase biology and drug discovery helps accelerate the development and evaluation of novel therapeutics.
Do read about some of the most popular patents of Carna Biosciences which have been covered by us in this article and also you can find Carna Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Carna Biosciences patent portfolio.
How many patents does Carna Biosciences have?
Carna Biosciences has a total of 313 patents globally. These patents belong to 49 unique patent families. Out of 313 patents, 187 patents are active.
How Many Patents did Carna Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Carna Biosciences Applications Filed | Carna Biosciences Patents Granted |
| 2026 | 4 | 10 |
| 2025 | 11 | 18 |
| 2024 | 16 | 25 |
| 2023 | 8 | 3 |
| 2022 | 30 | 5 |
| 2021 | 38 | 2 |
| 2020 | 44 | 9 |
| 2019 | 11 | 9 |
| 2018 | 1 | 18 |
| 2017 | 30 | 7 |
How many Carna Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Carna Biosciences File in Different Countries?
Countries in which Carna Biosciences Filed Patents
| Country | Patents |
| United States of America | 31 |
| Japan | 29 |
| Europe (EPO) | 23 |
| China | 23 |
| Australia | 14 |
| India | 14 |
| Korea (South) | 12 |
| Canada | 11 |
| Hong Kong (S.A.R.) | 10 |
| Germany | 9 |
| Austria | 8 |
| Taiwan | 7 |
| Brazil | 6 |
| Norway | 5 |
| New Zealand | 5 |
| South Africa | 5 |
| Mexico | 5 |
| Singapore | 5 |
| Israel | 5 |
| Spain | 4 |
| Russia | 4 |
| Italy | 4 |
| Denmark | 4 |
| Philippines | 3 |
| Indonesia | 3 |
| Malaysia | 3 |
| Finland | 2 |
| Costa Rica | 2 |
| Viet Nam | 2 |
| Eurasia | 2 |
| Chile | 1 |
| Hungary | 1 |
| Africa | 1 |
| Poland | 1 |
| Slovenia | 1 |
| Kenya | 1 |
| Croatia | 1 |
| Lithuania | 1 |
| Portugal | 1 |
| Turkey | 1 |
| Macao | 1 |
| Dominican Republic | 1 |
| Peru | 1 |
| Argentina | 1 |
| Colombia | 1 |
Where are Research Centres of Carna Biosciences Patents Located?
10 Best Carna Biosciences Patents
WO2013133367A1 is the most popular patent in the Carna Biosciences portfolio. It has received 98 citations so far from companies like Novartis, Agios Pharmaceuticals and Blueprint Medicines Corporation.
Below is the list of 10 most cited patents of Carna Biosciences:
| Publication Number | Citation Count |
| WO2013133367A1 | 98 |
| WO2021130638A1 | 85 |
| WO2009084695A1 | 63 |
| US20150011751A1 | 40 |
| WO2015115355A1 | 33 |
| WO2018097234A1 | 21 |
| WO2015012149A1 | 21 |
| WO2012133802A1 | 16 |
| JP2013104687A | 10 |
| WO2021153665A1 | 8 |
What Percentage of Carna Biosciences US Patent Applications were Granted?
Carna Biosciences (Excluding its subsidiaries) has filed 25 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 13 have been granted leading to a grant rate of 68.42%.
Below are the key stats of Carna Biosciences patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Carna Biosciences?
| Law Firm | Total Applications | Success Rate |
| Wenderoth Lind & Ponack Llp | 10 | 100.00% |
| Fenwick & West Llp | 4 | 75.00% |
| Panitch Schwarze Belisario & Nadel Llp | 4 | 25.00% |
| Whda Llp | 3 | 66.67% |
| Gilead Sciences Inc | 2 | 100.00% |
| Birch Stewart Kolasch & Birch Llp | 1 | 100.00% |
| Seed Intellectual Property Law Group Llp | 1 | 0.00% |
What are Carna Biosciences key innovation segments?
What Technologies are Covered by Carna Biosciences?
The chart below distributes patents filed by Carna Biosciences